Hemodynamic and Clinical Outcomes in Redo-Surgical Aortic Valve Replacement vs. Transcatheter Valve-in-Valve

Background: Transcatheter valve-in-valve replacement (ViV-TAVR) has emerged as an alternative to redo-surgical aortic valve replacement (Redo-SAVR) for the treatment of failed surgical aortic bioprostheses. However, the benefit of ViV-TAVR compared with Redo-SAVR remains debated with regard to short...

Full description

Bibliographic Details

Published in:	Structural Heart
Main Authors:	Sébastien Hecht, MSc, Anne-Sophie Zenses, PhD, Jérémy Bernard, MSc, Lionel Tastet, MSc, Nancy Côté, PhD, Leonardo de Freitas Campos Guimarães, MD, Jean-Michel Paradis, MD, Jonathan Beaudoin, MD, Kim O’Connor, MD, Mathieu Bernier, MD, Eric Dumont, MD, Dimitri Kalavrouziotis, MD, Robert Delarochellière, MD, Siamak Mohammadi, MD, Marie-Annick Clavel, DVM, PhD, Josep Rodés-Cabau, MD, Erwan Salaun, MD, PhD, Philippe Pibarot, DVM, PhD
Format:	Article
Language:	English
Published:	Elsevier 2022-11-01
Subjects:	Aortic bioprosthesis Redo-surgery Structural valve deterioration Transcatheter valve-in-valve
Online Access:	http://www.sciencedirect.com/science/article/pii/S2474870622019017